UB
ATRS

UMB Bank’s Antares Pharma, Inc. ATRS Stock Holding History

UMB Bank’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$4K – 2084
2022
Q1 		$4K Hold
1,000
– – ﹤0.01% 1731
2021
Q4 		$4K Buy
+1,000
New +$3.5K ﹤0.01% 1718

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UMB Bank's ATRS Position: Q2 2022 in Review

UMB Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,000 shares — an estimated $4K sold.

UMB Bank first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • UMB Bank reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • UMB Bank sold 1,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $4K.
  • UMB Bank first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
  • UMB Bank's Antares Pharma, Inc. position peaked at $4K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on UMB Bank's 13F filing for Q2 2022, filed 20 Jul 2022.